Home

sum Badekar subtropisk open label single arm study Baffle Du vil bli bedre tårn

Biology | Free Full-Text | Bright Light Therapy for Parkinson Disease: A  Literature Review and Meta-Analysis of Randomized Controlled Trials | HTML
Biology | Free Full-Text | Bright Light Therapy for Parkinson Disease: A Literature Review and Meta-Analysis of Randomized Controlled Trials | HTML

Open-label, multi-center, non-randomized, single-arm study to evaluate the  safety and efficacy of dendritic cell immunotherapy in patients with  refractory solid malignancies, on supportive care - Cytotherapy
Open-label, multi-center, non-randomized, single-arm study to evaluate the safety and efficacy of dendritic cell immunotherapy in patients with refractory solid malignancies, on supportive care - Cytotherapy

An Open-Label, Single-Arm, Efficacy Study of Tranexamic Acid in Adolescents  with Heavy Menstrual Bleeding - Journal of Pediatric and Adolescent  Gynecology
An Open-Label, Single-Arm, Efficacy Study of Tranexamic Acid in Adolescents with Heavy Menstrual Bleeding - Journal of Pediatric and Adolescent Gynecology

PDF] An open label, single-arm, phase II multicenter study of the safety  and efficacy of CG0070 oncolytic vector regimen in patients with  BCG-unresponsive non-muscle-invasive bladder cancer: Interim results. |  Semantic Scholar
PDF] An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results. | Semantic Scholar

Study 079 An OpenLabel SingleArm Phase 2 Trial
Study 079 An OpenLabel SingleArm Phase 2 Trial

CONSORT flow diagram. Patient allocation in single-arm open label pilot...  | Download Scientific Diagram
CONSORT flow diagram. Patient allocation in single-arm open label pilot... | Download Scientific Diagram

Stereotactic body radiation therapy with sequential S-1 for patients with  locally advanced pancreatic cancer and poor performance status: An open- label, single-arm, phase 2 trial - Radiotherapy and Oncology
Stereotactic body radiation therapy with sequential S-1 for patients with locally advanced pancreatic cancer and poor performance status: An open- label, single-arm, phase 2 trial - Radiotherapy and Oncology

Effect of Facial Cosmetic Acupuncture on Facial Elasticity: An Open-Label,  Single-Arm Pilot Study – topic of research paper in Clinical medicine.  Download scholarly article PDF and read for free on CyberLeninka open
Effect of Facial Cosmetic Acupuncture on Facial Elasticity: An Open-Label, Single-Arm Pilot Study – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open

Hanan Goldberg on Twitter: "Dr. De Wit presenting Keynote 057 study  results, a single arm open label study of pembrolizumab in NMIBC patients  unresponsive to BCG, demonstrating complete response rates of 38.8%!
Hanan Goldberg on Twitter: "Dr. De Wit presenting Keynote 057 study results, a single arm open label study of pembrolizumab in NMIBC patients unresponsive to BCG, demonstrating complete response rates of 38.8%!

PLOS ONE: A single-arm, open-label, phase 2 clinical trial evaluating  disease response following treatment with BI-505, a human  anti-intercellular adhesion molecule-1 monoclonal antibody, in patients  with smoldering multiple myeloma
PLOS ONE: A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma

An open label, single arm, prospective clinical study to evaluate liver  safety and tolerability of PUREMERIC™ (standardized extract from Curcuma  longa) in healthy subjects - ScienceDirect
An open label, single arm, prospective clinical study to evaluate liver safety and tolerability of PUREMERIC™ (standardized extract from Curcuma longa) in healthy subjects - ScienceDirect

Efficacy and Safety of Intrathecal Pemetrexed Combined With Dexamethasone  for Treating Tyrosine Kinase Inhibitor-Failed Leptomeningeal Metastases  From EGFR-Mutant NSCLC—a Prospective, Open-Label, Single-Arm Phase 1/2  Clinical Trial (Unique Identifier ...
Efficacy and Safety of Intrathecal Pemetrexed Combined With Dexamethasone for Treating Tyrosine Kinase Inhibitor-Failed Leptomeningeal Metastases From EGFR-Mutant NSCLC—a Prospective, Open-Label, Single-Arm Phase 1/2 Clinical Trial (Unique Identifier ...

Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis  previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label,  non-randomised, phase 2, multicentre study - The Lancet Haematology
Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study - The Lancet Haematology

PLOS ONE: Investigation of safety and efficacy of the new more thermostable  formulation of Flolan (epoprostenol) in Japanese patients with pulmonary  arterial hypertension (PAH)—An open-label, single-arm study
PLOS ONE: Investigation of safety and efficacy of the new more thermostable formulation of Flolan (epoprostenol) in Japanese patients with pulmonary arterial hypertension (PAH)—An open-label, single-arm study

A Phase III, Open-Label, Single-Arm Study of Tenecteplase for Restoration  of Function in Dysfunctional Central Venous Catheters - Journal of Vascular  and Interventional Radiology
A Phase III, Open-Label, Single-Arm Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters - Journal of Vascular and Interventional Radiology

Evaluation of apremilast in chronic pruritus of unknown origin: A  proof‐of‐concept, phase 2a, open‐label, single‐arm clinical trial - Clark -  2020 - Health Science Reports - Wiley Online Library
Evaluation of apremilast in chronic pruritus of unknown origin: A proof‐of‐concept, phase 2a, open‐label, single‐arm clinical trial - Clark - 2020 - Health Science Reports - Wiley Online Library

PDF] A single-arm, open-label study to assess the immunogenicity, safety,  and efficacy of etanercept manufactured using the serum-free, high-capacity  manufacturing process administered to patients with rheumatoid arthritis |  Semantic Scholar
PDF] A single-arm, open-label study to assess the immunogenicity, safety, and efficacy of etanercept manufactured using the serum-free, high-capacity manufacturing process administered to patients with rheumatoid arthritis | Semantic Scholar

Efficacy and safety of nivolumab in combination with ipilimumab in Japanese  patients with advanced melanoma: An open-label, single-arm, multicentre  phase II study - European Journal of Cancer
Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study - European Journal of Cancer

CONSORT flowchart for A single-arm, open-label, phase 2 clinical trial... |  Download Scientific Diagram
CONSORT flowchart for A single-arm, open-label, phase 2 clinical trial... | Download Scientific Diagram

ACURATE neo clinical trials - Boston Scientific
ACURATE neo clinical trials - Boston Scientific

The study was design as single-arm open-label trial consisting of a 14... |  Download Scientific Diagram
The study was design as single-arm open-label trial consisting of a 14... | Download Scientific Diagram

An Open-label, Single-arm Study of CRYO2 for Debulking at the Site of  Central Airway Obstruction or Stenosis | In Vivo
An Open-label, Single-arm Study of CRYO2 for Debulking at the Site of Central Airway Obstruction or Stenosis | In Vivo

Rationale and study design of MOTION: A phase 4, prospective, single-arm,  open-label study to measure outcomes in patients with pulmonary arterial  hypertension not on active treatment - Respiratory Medicine
Rationale and study design of MOTION: A phase 4, prospective, single-arm, open-label study to measure outcomes in patients with pulmonary arterial hypertension not on active treatment - Respiratory Medicine

New approaches to clinical trials: Adaptive designs - EUPATI Toolbox
New approaches to clinical trials: Adaptive designs - EUPATI Toolbox